President and Chief Executive Officer
Clinical development
Alexo Therapeutics
Ireland
Dr. Pons previously served as Chief Scientific Officer and site head of Rinat (Pfizer), where he was responsible for portfolio delivery from idea to clinical development. He implemented the vision of a company unit following biology across therapeutic areas while generating advanced antibody technologies and turned Rinat into the center of cancer immunology for Pfizer. Dr. Pons is an inventor of three antibodies in late-stage clinical development and has advanced nine additional antibodies into human trials in multiple therapeutic areas.
Cell biology Molecular biology Biotechnology Biochemistry